Efficacy of combined therapy of Diminaveto ® and Intromidium® in albino rats experimentally infected with Trypanosoma brucei brucei

AbstractThe chemotherapeutic effect of Diaminaveto ® (diminazene aceturate) and Intromidium® (isomethamidium chloride) combination in rats infected withTrypanosoma brucei was evaluated. Forty albino rats used for this study were grouped into 8 groups of 5 rats each. Rats in group 1 were not infected while group 2 –8 rats were inoculated intraperitoneally (i.p.) with 1 × 106 trypanosomes. Rats in group 2 were left untreated while group 3 and 4 rats were treated with 3.5  mg/kg Diaminaveto (DM) and 0.5 mg/kg Intromidium (IM) intramuscularly (i.m.) respectively at day 19 post infection (PI). Also, 7.0 mg/kg DM and 1.0 mg/kg IM were administered to rats in groups 5 and 6, respectively at the same day. Groups 7 and 8 were treated with 7.0 mg/kg DM and 1.0 mg/kg IM, respectively, at day 19 PI, and these treatments were reversed after 2 weeks (group 7 rats were treated with 1.0 mg/kg IM while rats in group 8 were treated with 7.0 mg/kg DM). Level of parasitemia, clinical signs, survivability, body weight changes, rectal temperature (RT), hematological ind ices (packed cell volume, hemoglobin concentration, white blood cell count, and differential leukocytic count), and rate of parasite clearance were used to evaluate the efficacies of the drugs and their combination. The parasites were cleared in the treated groups at day 21 PI (2 days post treatme nt). There was a remarkable (P <  0.05) reduction in PCV, Hb, WBCS, and weight of rats post infection (PI)....
Source: Comparative Clinical Pathology - Category: Pathology Source Type: research